The information on this website is intended to provide general drug information for UnitedHealthcare members. The information on this site is NOT specific to your benefit plan. If you are a UnitedHealthcare member, pleas register or log onto ® to find medical drug information specific to your benefit plan. Whether you are a UnitedHealthcare member or pre-enrollee, your medical drug benefit could differ greatly from the information provided here. This website should only be used for estimating purposes. If you are a pre-enrollee, and you would like to learn more about your specific medical drug benefit, please contact your employer. In addition we are providing a sample of a plan design offered in your market. This includes high level detail of all benefits provided, including prescription benefits.
A number of countries and foundations today pledged EUR million to help develop new treatments to fight against antibiotic resistance at a fundraising event for the Global Antibiotic Research and Development Partnership (GARDP). The meeting was hosted in Berlin by the German Federal Ministry of Health and the German Federal Ministry of Education and Research. GARDP was established in May 2016 as a non-profit research and development initiative by the World Health Organization (WHO) and the Drugs for Neglected Diseases initiative (DNDi). Funding will support GARDP’s four programme areas.